RxDoctor Payments Data

Robert Corniea

Internal Medicine · Provo, UTNPI 1447218664

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 37.3% of the total. Reporting peaked in 2019 at $560 and has fallen 97.4% since, to $15 in 2023.

$1,234in general payments, 2019–2025

Across 83 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$461
  • Johnson & Johnson$195
  • Novo Nordisk$76
  • AstraZeneca$75
  • Boehringer Ingelheim$61
  • Astellas Pharma US Inc$59
  • plus $308 from 15 others

What the payments were for

  • Food & beverage$1,21298%
  • Education$222%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,234 in reported general payments places this provider in the 75th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Other internal medicine in Provo

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →